Sinopharm Group news

About

Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.

Source: Wikipedia (CC BY-SA)

On coda.news

1 event, reported by media in 1 country

Latest news

economy2 d ago

Sinopharm Group announces plans to divest its medical management unit holding multiple state-owned hospitals.

According to Huxiu, Sinopharm Group plans to divest 70% of its stake in Sinopharm Medical Management Co., Ltd., a platform holding multiple state-owned hospitals. The company reported revenue of 3.112 billion yuan in 2025 and 1.449 billion yuan in the first half of 2026, while operating at a slight loss.

Similar companies

Sinopharm Group announces plans to divest its medical management unit holding multiple state-owned hospitals.

economy2 d ago

coda.news AI summary

The Beijing Equity Exchange disclosed on September 18 that two platforms under Sinopharm Group intend to transfer the 70% equity stake in a package.
Sinopharm Medical Management comprises five sectors, including Sinopharm Medical, which holds tertiary hospitals such as Xinxiang Central Hospital and Sinopharm Dongfeng General Hospital.
The formal transfer floor price for the equity has not yet been disclosed.

HuxiuRead original ↗